[Form 4] Phibro Animal Health Corporation Insider Trading Activity
David Glenn, Chief Financial Officer of Phibro Animal Health Corporation (PAHC), received a grant of restricted stock units (RSUs). The Form 4 reports an acquisition dated 08/15/2025 of 4,845 RSUs at a $0 price, bringing his total beneficial ownership to 34,845 shares of Class A Common Stock. The RSUs each represent a contingent right to one share and vest in substantially equal installments on each of the first three anniversaries of August 1, 2025, subject to continued employment. The filing was signed by an attorney-in-fact on 08/19/2025. The disclosure reflects a routine executive equity award with time-based vesting.
David Glenn, Chief Financial Officer di Phibro Animal Health Corporation (PAHC), ha ricevuto una concessione di restricted stock units (RSU). Il Form 4 segnala un'acquisizione datata 15/08/2025 di 4.845 RSU a prezzo $0, portando la sua partecipazione beneficiaria totale a 34.845 azioni di Class A Common Stock. Le RSU rappresentano ciascuna il diritto condizionato a una azione e maturano in rate sostanzialmente uguali nei primi tre anniversari del 1掳 agosto 2025, subordinatamente alla continuazione del rapporto di lavoro. Il documento 猫 stato firmato da un procuratore il 19/08/2025. La comunicazione riflette un tipico premio azionario per dirigenti con maturazione basata sul tempo.
David Glenn, Director Financiero de Phibro Animal Health Corporation (PAHC), recibi贸 una concesi贸n de restricted stock units (RSU). El Formulario 4 informa una adquisici贸n con fecha 15/08/2025 de 4.845 RSU a precio $0, elevando su propiedad beneficiaria total a 34.845 acciones de Class A Common Stock. Las RSU representan cada una un derecho contingente a una acci贸n y vencen en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo. La presentaci贸n fue firmada por un apoderado el 19/08/2025. La divulgaci贸n refleja una concesi贸n ejecutiva rutinaria con adquisici贸n por tiempo.
Phibro Animal Health Corporation(PAHC)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO)鞚� David Glenn鞚� 鞝滍暅臁瓣贝攵�欤检嫕雼渼(RSUs)毳� 攵�鞐皼鞎橃姷雼堧嫟. Form 4電� 2025-08-15鞚检瀽搿� 4,845 RSU毳� 臧�瓴� $0鞐� 旆摑頄堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措鞃� 攴胳潣 齑� 鞁れ 氤挫湢歆�攵勳潃 Class A 氤错喌欤� 34,845欤�臧� 霅橃棃鞀惦媹雼�. 臧� RSU電� 頃� 欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雮措┌, 2025雲� 8鞗� 1鞚�鞚� 鞁滌瀾鞙茧 觳� 靹� 氩堨Ц 旮半厫鞚检棎 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 攵勴暊頃橃棳 氩犾姢韺呺悩氅� 瓿勳啀 攴茧臧� 臁瓣贝鞛呺媹雼�. 頃措嫻 鞝滌稖靹滊姅 2025-08-19鞐� 雽�毽澑鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞚� 瓿奠嫓電� 鞁滉皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橂姅 韱奠儊鞝侅澑 瓴届榿歆� 欤检嫕 氤挫儊鞛勳潉 氚橃榿頃╇媹雼�.
David Glenn, directeur financier de Phibro Animal Health Corporation (PAHC), a re莽u une attribution de restricted stock units (RSU). Le formulaire 4 signale une acquisition en date du 15/08/2025 de 4 845 RSU 脿 un prix de 0 $, portant sa d茅tention b茅n茅ficiaire totale 脿 34 845 actions de Class A Common Stock. Les RSU repr茅sentent chacune un droit conditionnel 脿 une action et acqui猫rent en parts sensiblement 茅gales lors de chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi. Le d茅p么t a 茅t茅 sign茅 par un mandataire le 19/08/2025. Cette divulgation refl猫te une attribution d'actions de dirigeant de routine avec acquisition fond茅e sur le temps.
David Glenn, Chief Financial Officer von Phibro Animal Health Corporation (PAHC), erhielt eine Zuteilung von Restricted Stock Units (RSUs). Das Formular 4 meldet einen Erwerb datiert auf den 15.08.2025 von 4.845 RSUs zu $0, wodurch sein gesamtes wirtschaftliches Eigentum auf 34.845 Aktien der Class A Common Stock ansteigt. Die RSUs verbriefen jeweils ein bedingtes Recht auf eine Aktie und werden in ann盲hernd gleichen Raten an den ersten drei Jahrestagen des 1. August 2025 f盲llig, vorbehaltlich fortgesetzter Besch盲ftigung. Die Einreichung wurde am 19.08.2025 von einem Bevollm盲chtigten unterzeichnet. Die Offenlegung stellt eine routinem盲脽ige Aktienzuteilung f眉r F眉hrungskr盲fte mit zeitbasierter Vestingregelung dar.
- None.
- None.
Insights
TL;DR: A time鈥慴ased RSU grant to the CFO increased reported beneficial ownership to 34,845 shares; this is a routine compensation disclosure.
The Form 4 documents a grant of 4,845 restricted stock units at no cash price, reflecting standard equity compensation to align management incentives over a three鈥憏ear vesting schedule starting August 1, 2025. There are no exercises, sales, or derivative transactions reported. From an investor perspective, the filing is informational and does not itself indicate a material change to company fundamentals.
TL;DR: Reported RSU award to the CFO follows common governance practice for retention and alignment; disclosure appears complete and timely.
The filing specifies the grant, vesting timetable, and resulting beneficial ownership, fulfilling Section 16 reporting requirements. The RSUs vest in substantially equal installments over three anniversaries, contingent on continued employment. The signature by an attorney鈥慽n鈥慺act is dated 08/19/2025, consistent with administrative processing of insider filings.
David Glenn, Chief Financial Officer di Phibro Animal Health Corporation (PAHC), ha ricevuto una concessione di restricted stock units (RSU). Il Form 4 segnala un'acquisizione datata 15/08/2025 di 4.845 RSU a prezzo $0, portando la sua partecipazione beneficiaria totale a 34.845 azioni di Class A Common Stock. Le RSU rappresentano ciascuna il diritto condizionato a una azione e maturano in rate sostanzialmente uguali nei primi tre anniversari del 1掳 agosto 2025, subordinatamente alla continuazione del rapporto di lavoro. Il documento 猫 stato firmato da un procuratore il 19/08/2025. La comunicazione riflette un tipico premio azionario per dirigenti con maturazione basata sul tempo.
David Glenn, Director Financiero de Phibro Animal Health Corporation (PAHC), recibi贸 una concesi贸n de restricted stock units (RSU). El Formulario 4 informa una adquisici贸n con fecha 15/08/2025 de 4.845 RSU a precio $0, elevando su propiedad beneficiaria total a 34.845 acciones de Class A Common Stock. Las RSU representan cada una un derecho contingente a una acci贸n y vencen en cuotas sustancialmente iguales en cada uno de los primeros tres aniversarios del 1 de agosto de 2025, sujeto a la continuidad del empleo. La presentaci贸n fue firmada por un apoderado el 19/08/2025. La divulgaci贸n refleja una concesi贸n ejecutiva rutinaria con adquisici贸n por tiempo.
Phibro Animal Health Corporation(PAHC)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO)鞚� David Glenn鞚� 鞝滍暅臁瓣贝攵�欤检嫕雼渼(RSUs)毳� 攵�鞐皼鞎橃姷雼堧嫟. Form 4電� 2025-08-15鞚检瀽搿� 4,845 RSU毳� 臧�瓴� $0鞐� 旆摑頄堨潓鞚� 氤搓碃頄堨溂氅�, 鞚措鞃� 攴胳潣 齑� 鞁れ 氤挫湢歆�攵勳潃 Class A 氤错喌欤� 34,845欤�臧� 霅橃棃鞀惦媹雼�. 臧� RSU電� 頃� 欤检棎 雽�頃� 臁瓣贝攵� 甓岆Μ毳� 雮橅儉雮措┌, 2025雲� 8鞗� 1鞚�鞚� 鞁滌瀾鞙茧 觳� 靹� 氩堨Ц 旮半厫鞚检棎 鞁れ鞝侅溂搿� 霃欖澕頃� 牍勳湪搿� 攵勴暊頃橃棳 氩犾姢韺呺悩氅� 瓿勳啀 攴茧臧� 臁瓣贝鞛呺媹雼�. 頃措嫻 鞝滌稖靹滊姅 2025-08-19鞐� 雽�毽澑鞐� 鞚橅暣 靹滊獏霅橃棃鞀惦媹雼�. 鞚� 瓿奠嫓電� 鞁滉皠 旮半皹 氩犾姢韺呾澊 鞝侅毄霅橂姅 韱奠儊鞝侅澑 瓴届榿歆� 欤检嫕 氤挫儊鞛勳潉 氚橃榿頃╇媹雼�.
David Glenn, directeur financier de Phibro Animal Health Corporation (PAHC), a re莽u une attribution de restricted stock units (RSU). Le formulaire 4 signale une acquisition en date du 15/08/2025 de 4 845 RSU 脿 un prix de 0 $, portant sa d茅tention b茅n茅ficiaire totale 脿 34 845 actions de Class A Common Stock. Les RSU repr茅sentent chacune un droit conditionnel 脿 une action et acqui猫rent en parts sensiblement 茅gales lors de chacun des trois premiers anniversaires du 1er ao没t 2025, sous r茅serve de la poursuite de l'emploi. Le d茅p么t a 茅t茅 sign茅 par un mandataire le 19/08/2025. Cette divulgation refl猫te une attribution d'actions de dirigeant de routine avec acquisition fond茅e sur le temps.
David Glenn, Chief Financial Officer von Phibro Animal Health Corporation (PAHC), erhielt eine Zuteilung von Restricted Stock Units (RSUs). Das Formular 4 meldet einen Erwerb datiert auf den 15.08.2025 von 4.845 RSUs zu $0, wodurch sein gesamtes wirtschaftliches Eigentum auf 34.845 Aktien der Class A Common Stock ansteigt. Die RSUs verbriefen jeweils ein bedingtes Recht auf eine Aktie und werden in ann盲hernd gleichen Raten an den ersten drei Jahrestagen des 1. August 2025 f盲llig, vorbehaltlich fortgesetzter Besch盲ftigung. Die Einreichung wurde am 19.08.2025 von einem Bevollm盲chtigten unterzeichnet. Die Offenlegung stellt eine routinem盲脽ige Aktienzuteilung f眉r F眉hrungskr盲fte mit zeitbasierter Vestingregelung dar.
FAQ
What did PAHC CFO David Glenn report on the Form 4?
At what price were the RSUs granted to David Glenn (PAHC)?
When do the RSUs granted to PAHC's CFO vest?
How many shares does David Glenn beneficially own after the reported transaction?
Who signed the Form 4 for David Glenn and when?
